We are live on ! Find out more
DKCM

Davidson Kempner Capital Management Portfolio holdings

AUM $7.33B
1-Year Est. Return 56.47%
This Fund
S&P 500
This Quarter Est. Return
+16.17%
1 Year Est. Return
+56.47%
3 Year Est. Return
+139.87%
5 Year Est. Return
+217.47%
10 Year Est. Return
+1,125.15%
AUM
$8.53B
AUM Growth
+$1.5B
Cap. Flow
-$412M
Cap. Flow %
-4.83%
Top 10 Hldgs %
38.42%
Holding
388
New
122
Increased
28
Reduced
67
Closed
106

Sector Composition

Rank Sector Weight
1 Healthcare 20.38%
2 Technology 13.86%
3 Consumer Discretionary 8.94%
4 Communication Services 7.57%
5 Financials 6.74%

Similar funds

Davidson Kempner Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Davidson Kempner Capital Management held 388 positions worth $8.53B, up 21% from $7.03B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Davidson Kempner Capital Management withdrew a net $412M in Q4 2020, closing 106 positions and reducing 67 holdings. Its most notable exit was Immunomedics Inc, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Davidson Kempner Capital Management opened a new position in Xilinx Inc worth $419M.

  • Davidson Kempner Capital Management's largest Q4 2020 buy was Xilinx Inc: 2,961,924 shares worth $419M.
  • Davidson Kempner Capital Management added most to ARKO Corp in Q4 2020, an estimated $227M increase.
  • Davidson Kempner Capital Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $125M.
  • Davidson Kempner Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $258M.
  • Davidson Kempner Capital Management's ten largest holdings make up 38% of its $8.53B portfolio in Q4 2020.
  • Davidson Kempner Capital Management opened 122 new positions and closed 106 in Q4 2020.
  • Davidson Kempner Capital Management's portfolio value rose 21% quarter-over-quarter to $8.53B.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.